Array BioPharma Inc. (NASDAQ: ARRY) received an additional $40 million funding commitment from Deerfield Management, a healthcare investment organization and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE